JAZZ vs MDT: fair value comparison
Jazz Pharmaceuticals plc and Medtronic plc · Updated 2026-10-19
JAZZ currently screens as fairly valued while MDT screens as undervalued. Within Healthcare, MDT currently sits closer to the top of our ranking by discount to fair value. MDT carries the stronger quality grade.
| JAZZ | MDT | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $210.23 | $88.48 |
| 12-month range | $131.16–$261.62 | $73.75–$105.35 |
| Rank by discount to fair value | #45 of 108 Healthcare | #41 of 108 Healthcare |
| Quality grade | B | A |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Modest |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | Undervalued | Overvalued |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: JAZZ fair value analysis · MDT fair value analysis